Literature DB >> 23052749

Living donor liver transplantation for hepatitis C.

Yasutsugu Takada1, Shinji Uemoto.   

Abstract

Liver cirrhosis and hepatocellular carcinoma related to chronic hepatitis C virus (HCV) infection are currently the most common indications for liver transplantation. The number of living donor liver transplantation (LDLT) procedures has increased given the shortage of donor organs from deceased donors. However, recurrence of HCV infection is universal and affects graft survival. This mini-review compared the outcomes for HCV-positive recipients after LDLT with those after deceased donor liver transplantation.

Entities:  

Mesh:

Year:  2012        PMID: 23052749     DOI: 10.1007/s00595-012-0361-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  32 in total

1.  Is severe recurrent hepatitis C more common after adult living donor liver transplantation?

Authors:  Mark W Russo; Roshan Shrestha
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

Review 2.  What determines the natural history of recurrent hepatitis C after liver transplantation?

Authors:  Marina Berenguer
Journal:  J Hepatol       Date:  2005-04       Impact factor: 25.083

3.  High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

Authors:  M Prieto; M Berenguer; J M Rayón; J Córdoba; L Argüello; D Carrasco; A García-Herola; V Olaso; M De Juan; M Gobernado; J Mir; J Berenguer
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

4.  Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.

Authors:  Norah A Terrault; Mitchell L Shiffman; Anna S F Lok; Sammy Saab; Lan Tong; Robert S Brown; Gregory T Everson; K Rajender Reddy; Jeffrey H Fair; Laura M Kulik; Timothy L Pruett; Leonard B Seeff
Journal:  Liver Transpl       Date:  2007-01       Impact factor: 5.799

5.  Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.

Authors:  Ashokkumar Jain; Ashish Singhal; Randeep Kashyap; Saman Safadjou; Charlotte K Ryan; Mark S Orloff
Journal:  Transplantation       Date:  2011-08-27       Impact factor: 4.939

6.  Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States.

Authors:  Mark W Russo; Joseph Galanko; Kimberly Beavers; Michael W Fried; Roshan Shrestha
Journal:  Liver Transpl       Date:  2004-03       Impact factor: 5.799

7.  Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.

Authors:  Marina Berenguer; Martín Prieto; Fernando San Juan; José M Rayón; Fernando Martinez; Domingo Carrasco; Angel Moya; Francisco Orbis; José Mir; Joaquín Berenguer
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

8.  Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.

Authors:  Yasutsugu Takada; Hironori Haga; Takashi Ito; Motoshige Nabeshima; Kohei Ogawa; Mureo Kasahara; Fumitaka Oike; Mikiko Ueda; Hiroto Egawa; Koichi Tanaka
Journal:  Transplantation       Date:  2006-02-15       Impact factor: 4.939

9.  Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry.

Authors:  René Adam; Paul McMaster; John G O'Grady; Denis Castaing; Jurgen L Klempnauer; Neville Jamieson; Peter Neuhaus; Jan Lerut; Mauro Salizzoni; Stephen Pollard; Ferdinand Muhlbacher; Xavier Rogiers; Juan Carlos Garcia Valdecasas; Joaquin Berenguer; Daniel Jaeck; Enrique Moreno Gonzalez
Journal:  Liver Transpl       Date:  2003-12       Impact factor: 5.799

10.  Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors.

Authors:  Paul J Gaglio; Srikar Malireddy; Brian S Levitt; Dianne Lapointe-Rudow; Jay Lefkowitch; Milan Kinkhabwala; Mark W Russo; Jean C Emond; Robert S Brown
Journal:  Liver Transpl       Date:  2003-10       Impact factor: 5.799

View more
  2 in total

1.  Liver transplantation for advanced hepatocellular carcinoma in patients with Child-Pugh A and B.

Authors:  Ahmed Hammad; Toshimi Kaido; Kohei Ogawa; Yasuhiro Fujimoto; Tadahiro Uemura; Akira Mori; Etsuro Hatano; Hideaki Okajima; Shinji Uemoto
Journal:  Surg Today       Date:  2015-02-27       Impact factor: 2.549

2.  Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot "Prunus mume".

Authors:  Takashi Hoshino; Hitoshi Takagi; Atsushi Naganuma; Eri Koitabashi; Sanae Uehara; Naomi Sakamoto; Tomohiro Kudo; Ken Sato; Satoru Kakizaki
Journal:  World J Hepatol       Date:  2013-10-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.